You are here

P&T News

August 28

Despite Savings from Pilot Programs, Medicaid Costs Have Soared
JAMA Study of 1,500 Drugs Crunches the Numbers
Orphan Drug May Provide Complete Corneal Healing in Some Patients
Warning Letters Issued for Products Resembling Juice Boxes, Cookies and Candy

August 21

Drug Companies Fight Back, Claiming First Amendment Violation
Battle of the Auto-Injectors May Lead to Lower Costs for Patients

August 13

New Algorithm Surveys Alterations in DNA and Millions of Points in the Human Genome
First Oral Drug Increases Activity of the Body’s Deficient Enzyme
Venous Thromboembolism and Other Risks to Be Evaluated in Postmarketing Studies

August 7

Researchers Recommend Increased Testing for Men
New Draft Guidance Seeks to Better Target Patient Needs
It’s All in How the Data Are Analyzed

July 31

Two Phase 3 Studies Met Endpoint of Complete Clearance of Lesions
Radiation Exposure Remains a Risk
Quality Metrics Will Provide Feedback to Manufacturers
Drugmaker Aiming for 25–30 New Drugs by 2022